Pfizer Wysolone DT price challenge denied: DoP upholds NPPA ceiling on Prednisolone Tablets Farhat Nasim2 Nov 2024 1:00 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has upheld a price ceiling order issued by the National Pharmaceutical Pricing Authority (NPPA) on...
Lupin Gets CDSCO Panel Nod to Study Antidiabetic FDC Dr. Divya Colin1 Nov 2024 6:00 PM ISTNew Delhi: The drug major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
La Renon's plea to exempt Sodium Valproate from NPPA price cap rejected Farhat Nasim31 Oct 2024 2:00 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP), functional under India's Ministry of Chemicals and Fertilizers, has rejected an appeal from La...
DoP orders NPPA to reassess price of Cipla's Advent, Synclar and Azee drugs Farhat Nasim30 Oct 2024 6:14 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP), under the Ministry of Chemicals & Fertilizers, has issued orders to the National...
Reduce price of 3 anti-cancer drugs: Govt asks manufacturers Ruchika Sharma29 Oct 2024 5:46 PM ISTNew Delhi: To ensure the affordable availability of drugs, the government has asked the companies to reduce the prices of three anti-cancer drugs,...
49 drugs samples including PAN 40, Calvam 625, Zerodol-SP Tablet fail to meet CDSCO quality test Ruchika Sharma28 Oct 2024 6:18 PM ISTNew Delhi: In its latest drug alert, the Central Drug Standard Control Organization (CDSCO) has flagged forty-nine medicine batches for failing to...
Severe risk with import of second hand CT scanners, MRI machines, surgical robots, warns industry body, files PIL Farhat Nasim27 Oct 2024 12:30 PM ISTNew Delhi: Medical device manufacturers in India are sounding alarms over the unregulated import of refurbished medical devices, emphasizing serious...
No violation of Abbott's trademark: Delhi HC upholds trademark of Mebufen against Brufen Farhat Nasim26 Oct 2024 5:18 PM ISTNew Delhi: The Delhi High Court has upheld the Registrar of Trademarks' decision to reject an objection by pharmaceutical giant Abbott, which...
'Insulin Tablets' banned, License of pharma firm cancelled after activist flags mislabeling risks for diabetics Farhat Nasim25 Oct 2024 1:31 PM ISTNew Delhi: The license of Bhargava Phytolabs, a Rajasthan-based pharmaceutical company, has been cancelled for manufacturing "Insulin Tablets," a...
Only D.Pharm, B.Pharm, M.Pharm, Pharm.D Holders Can Be Drug Wholesalers: DTAB Farhat Nasim24 Oct 2024 6:02 PM ISTNew Delhi: The Drugs Technical Advisory Board (DTAB) has reaffirmed its recommendation to finalize amendment to Rule 64 of the Drugs Rules, 1945,...
DoP rejects application challenging NPPA price fixation order on Metoprolol Farhat Nasim23 Oct 2024 6:37 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has rejected a review application filed by Ajanta Pharma against price fixation order issued by...
Mankind Pharma CALDIKIND-P gets Delhi HC protection from lookalike CALIKA-P Farhat Nasim22 Oct 2024 6:05 PM ISTNew Delhi: In relief to Mankind Pharma, the Delhi High Court has prohibited Sanshiv Health Tech from marketing its product CALIKA-P as it found the...
